Uwe Demelbauer

509 total citations
10 papers, 433 citations indexed

About

Uwe Demelbauer is a scholar working on Molecular Biology, Spectroscopy and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Uwe Demelbauer has authored 10 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Spectroscopy and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Uwe Demelbauer's work include Glycosylation and Glycoproteins Research (7 papers), Protein purification and stability (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Uwe Demelbauer is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Protein purification and stability (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Uwe Demelbauer collaborates with scholars based in Austria, Germany and Czechia. Uwe Demelbauer's co-authors include Matthias Pelzing, Andreas Rizzi, Günter Allmaier, Christian Neusüß, Djuro Josić, Victòria Sanz‐Nebot, Christian Neusüß, José Barbosa, Elvira Balaguer and Martin Zehl and has published in prestigious journals such as Journal of Chromatography A, Pharmaceutical Research and Analytical and Bioanalytical Chemistry.

In The Last Decade

Uwe Demelbauer

10 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uwe Demelbauer Austria 9 301 184 118 79 61 10 433
Miyako Ohta Japan 11 352 1.2× 184 1.0× 44 0.4× 47 0.6× 126 2.1× 18 460
Sara Ongay Netherlands 11 290 1.0× 194 1.1× 88 0.7× 46 0.6× 29 0.5× 17 445
Zoltán Szabó United States 11 402 1.3× 123 0.7× 92 0.8× 175 2.2× 119 2.0× 14 453
Michaela Hook Netherlands 9 541 1.8× 157 0.9× 62 0.5× 388 4.9× 57 0.9× 12 596
Feilei Huang United States 13 259 0.9× 158 0.9× 46 0.4× 51 0.6× 10 0.2× 15 377
Qiao Duan China 9 296 1.0× 51 0.3× 59 0.5× 23 0.3× 25 0.4× 14 382
Benjamin Spangler United States 7 178 0.6× 63 0.3× 35 0.3× 24 0.3× 40 0.7× 8 335
Ikuko Ishii‐Karakasa Japan 13 245 0.8× 35 0.2× 9 0.1× 133 1.7× 119 2.0× 20 358
Kwang Hoe Kim South Korea 12 281 0.9× 165 0.9× 16 0.1× 38 0.5× 49 0.8× 23 350
Jeffrey B. Wheatley United States 11 424 1.4× 93 0.5× 70 0.6× 47 0.6× 46 0.8× 15 524

Countries citing papers authored by Uwe Demelbauer

Since Specialization
Citations

This map shows the geographic impact of Uwe Demelbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Demelbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Demelbauer more than expected).

Fields of papers citing papers by Uwe Demelbauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Demelbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Demelbauer. The network helps show where Uwe Demelbauer may publish in the future.

Co-authorship network of co-authors of Uwe Demelbauer

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Demelbauer. A scholar is included among the top collaborators of Uwe Demelbauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Demelbauer. Uwe Demelbauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Higel, Fabian, Andreas Seidl, Uwe Demelbauer, et al.. (2015). N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 Biopharmaceutical. Pharmaceutical Research. 32(11). 3649–3659. 13 indexed citations
2.
Higel, Fabian, Andreas Seidl, Uwe Demelbauer, Fritz Sörgel, & Wolfgang Frieß. (2014). Small scale affinity purification and high sensitivity reversed phase nanoLC-MS N-glycan characterization of mAbs and fusion proteins. mAbs. 6(4). 894–903. 9 indexed citations
3.
Higel, Fabian, Uwe Demelbauer, Andreas Seidl, Wolfgang Frieß, & Fritz Sörgel. (2013). Reversed-phase liquid-chromatographic mass spectrometric N-glycan analysis of biopharmaceuticals. Analytical and Bioanalytical Chemistry. 405(8). 2481–2493. 49 indexed citations
4.
Balaguer, Elvira, Uwe Demelbauer, Matthias Pelzing, et al.. (2006). Glycoform characterization of erythropoietin combining glycan and intact protein analysis by capillary electrophoresis – electrospray – time‐of‐flight mass spectrometry. Electrophoresis. 27(13). 2638–2650. 100 indexed citations
5.
Demelbauer, Uwe, et al.. (2005). On the variation of glycosylation in human plasma derived antithrombin. Journal of Chromatography A. 1080(1). 15–21. 30 indexed citations
7.
Neusüß, Christian, Uwe Demelbauer, & Matthias Pelzing. (2005). Glycoform characterization of intact erythropoietin by capillary electrophoresis‐electrospray‐time of flight‐mass spectrometry. Electrophoresis. 26(7-8). 1442–1450. 80 indexed citations
10.
Musenga, Alessandro, Andreas Schedle, Uwe Demelbauer, et al.. (2004). Separation of ethoxylated bisphenol A dimethacrylates in dental composite after derivatisation to ionisable amines by capillary zone electrophoresis. Journal of Chromatography A. 1034(1-2). 221–226. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026